Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. The international study led by a Virginia Commonwealth University researcher found the medication semaglutide,

Results showed that 62.9% of patients on Ozempic saw a reduction in liver inflammation, compared to 34.3% on placebo. Additionally, 36.8% of those treated with Ozempic experienced improvement in liver fibrosis versus 22.4% of the placebo group.

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, according to the New England Journal of Medicine.